Send to

Choose Destination
See comment in PubMed Commons below
Neuroreport. 2007 Jul 16;18(11):1181-5.

Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats.

Author information

Department of Physiology, Faculty of Medicine, Neuroscience Research Center of Shandong Province, Qingdao University, Qingdao, Shandong, PR China.


The effects of myricetin on 6-hydroxydopamine (6-OHDA)-induced neurodegeneration in the substantia nigra-striatum system were investigated. By high-performance liquid chromatography electrochemical detection, we showed that the dopamine content in the striatum decreased after 6-OHDA treatment, which could be restored by myricetin. The immunohistochemistry and semiquantitative reverse transcription-PCR studies showed that myricetin could prevent the 6-OHDA-induced decrease of tyrosine hydroxylase positive neurons and the tyrosine hydroxylase mRNA expression in the substantia nigra. Perls' iron staining study further demonstrated that myricetin prevented the 6-OHDA-induced increase of iron-staining cells in the substantia nigra. These results suggested that the protective effects of myricetin on the toxicity of 6-OHDA could be attributed to the myricetin-suppressed iron toxicity.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons


    Supplemental Content

    Full text links

    Icon for Wolters Kluwer
    Loading ...
    Support Center